Finance

Lists
DOC:NYSE
Healthpeak Properties, Inc
$20.12
-1.30%
(-0.26) 1D
$20.13
+0.05% (+0.0100)
After hours
Closed: Nov 12, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DOC...
Open
$20.44
High
$20.49
Low
$20.05
Mkt. cap
13.87B
Avg. vol.
6.26M
Volume
5.36M
Dividend
6.06%
Quarterly dividend
$0.31
Ex-dividend date
Dec 18, 2026
P/E ratio
37.03
52-wk high
$22.95
52-wk low
$15.70
EPS
$0.54
Beta
1.04
Shares outstanding
689.54M
No. of employees
411
Open
$20.44
High
$20.49
Low
$20.05
Mkt. cap
13.87B
Avg. vol.
6.26M
Volume
5.36M
Dividend
6.06%
Quarterly dividend
$0.31
Ex-dividend date
Dec 18, 2026
P/E ratio
37.03
52-wk high
$22.95
52-wk low
$15.70
EPS
$0.54
Beta
1.04
Shares outstanding
689.54M
No. of employees
411
News stories
From web sources and news partners
Profile
Healthpeak Properties, Inc. is an American real estate investment trust that invests in senior housing, life science labs, and medical offices. As of December 31, 2025, the company owned interests in 689 properties. Wikipedia
About Healthpeak Properties, Inc
CEOScott M. Brinker
Employees411
FoundedMar 1985
HeadquartersDenver, Colorado, United States
SectorReal Estate
IndustryReal estate investment trust
Websitehcpi.com
Analyst ratings
Based on 12 analysts giving stock ratings to DOC in the past 3 months
Hold
Buy
2
Hold
10
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for DOC in the last 3 months.
Highest
Current $20.12
$25.00 (+24.25%)
Average
$22.10 (+9.84%)
Lowest
$21.00 (+4.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Goldsmith
UBS
Hold
Reiterated
$22.00
+9.3%
11/11/2026
Farrell Granath
Bank of America Securities
Buy
Reiterated
$25.00
+24.3%
11/09/2026
Michael Carroll
RBC Capital
Buy
Maintained
$24.00
+19.3%
11/09/2026
Richard Anderson
Cantor Fitzgerald
Hold
Reiterated
$21.00
+4.4%
11/03/2026
John Kilichowski
Wells Fargo
Hold
Maintained
-
-
11/03/2026
Nicholas Yulico
Scotiabank
Hold
Maintained
$21.00
+4.4%
11/03/2026
Ronald Kamdem
Morgan Stanley
Hold
Maintained
$22.00
+9.3%
11/03/2026
Richard Hightower
Barclays
Hold
Maintained
$21.00
+4.4%
10/13/2026
Dave Rodgers
Raymond James
Hold
Maintained
-
-
10/06/2026
James Kammert
Evercore ISI
Hold
Maintained
$22.00
+9.3%
09/21/2026
Joe Dickstein
Jefferies
Hold
Initiated
$21.00
+4.4%
09/15/2026
Michael Mueller
J.P. Morgan
Hold
Maintained
$22.00
+9.3%
08/18/2026
Nicholas Joseph
Citi
Hold
Maintained
$22.00
+9.3%
08/11/2026
Vikram Malhotra
Mizuho Securities
Buy
Maintained
$24.00
+19.3%
07/06/2026
Unknown Analyst
Raymond James
Hold
Initiated
$24.00
+19.3%
06/16/2026
Juan C. Sanabria
BMO Capital
Buy
Maintained
$24.00
+19.3%
06/15/2026
Wes Golladay
Robert W. Baird
Buy
Maintained
$21.00
+4.4%
05/13/2026
Marie Ferguson
Argus Research
Hold
Downgraded
-
-
02/05/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
$0.04 / $0.03
+54.40%beat
Revenue / Est. (USD)
820.89M / 743.51M
+10.41%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
719.40M
752.95M
771.58M
820.89M
Cost of goods sold
279.33M
345.96M
342.30M
389.13M
Cost of revenue
279.33M
345.96M
342.30M
389.13M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.63M
24.59M
22.52M
23.59M
Operating expense
295.71M
314.32M
305.91M
322.51M
Total operating expenses
575.04M
660.28M
648.20M
711.64M
Operating income
144.36M
92.67M
123.38M
109.25M
Other non operating income
11.14M
1.47M
12.35M
670.00K
EBT including unusual items
127.82M
199.91M
61.84M
37.97M
EBT excluding unusual items
77.57M
11.12M
45.96M
37.76M
Income tax expense
6.03M
254.00K
-1.40M
1.29M
Effective tax rate
4.72%
0.13%
-2.27%
3.39%
Other operating expenses
-
-
-
-
Net income
113.97M
193.63M
52.82M
17.26M
Net profit margin
15.84%
25.72%
6.85%
2.10%
Earnings per share
0.10
-
-
0.04
Interest and investment income
-
-
-
8.00M
Interest expense
-80.64M
-87.29M
-92.28M
-83.90M
Net interest expenses
-80.64M
-87.29M
-92.28M
-75.90M
Depreciation and amortization charges
262.09M
289.73M
283.39M
298.92M
EBITDA
369.95M
375.81M
400.46M
401.61M
Gain or loss from assets sale
-56.35M
-50.67M
-9.99M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps